Community/Retail

The FDA has approved Adynovate from Shire, an extended circulating half-life recombinant Factor VIII treatment for hemophilia A in pediatric patients younger than age 12.

Over the years, a number of landmark clinical studies in virology have been published, shaping how we treat the disease today.

Over the years, a number of landmark clinical studies in the field of virology have been published, shaping how we treat many infectious diseases today

Acute flaccid myelitis (AFM) is a rare condition that affects the nervous system and can be caused by viral infections.

Excitement, nervousness, and fear may all overcome you as you approach graduation. This is normal I assure you!

Writing books is a great way to open new doors, or open the doors that currently might be closed to you.

The New Year can be an exciting time filled with celebration, family, and friends.

Hospitalization and death is more likely among individuals with diabetes when they contract influenza than when healthy individuals do, and so influenza vaccination uptake is an important area of scrutiny.

AstraZeneca and Eli Lilly are expanding their collaboration to develop an Alzheimer’s drug known as MEDI1814, an antibody selective for amyloid-beta 42.

Ability Pharmaceuticals has received Orphan Drug Designation from the FDA for ABTL0812, its product designed to treat pancreatic cancer.

The researchers vaccinated known contacts of people with newly diagnosed Ebola infection. Some were vaccinated immediately, some not for 21 days. In all, there were 2,151 people vaccinated.

The FDA has approved Spinraza (nusinersen) for the treatment of spinal muscular atrophy (SMA) in adults and children

Heroin and oxycodone topped the list of drugs involved in overdose deaths in recent years, according to a report released by the CDC.

The FDA recently approved an Investigational New Drug application submitted by Valneva SE.

Many pharmacists are active members of the scientific community and often publish their research in peer-reviewed journals. The h-index is commonly used as a measure of scientific productivity that pharmacists who publish should be aware of.

Priority review voucher program is designed to focus attention on otherwise neglected diseases.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Walgreens has launched its safe medication disposal kiosk program in New Jersey with the installation of drug take-back kiosks at 16 Walgreens drugstores.

Screening tools are needed so that health care professionals can offer immunizations at every convenient opportunity.

Baxter has entered a definitive agreement for the acquisition of India-based Claris Injectables for $625 million.

Currently, the treatment duration of acute otitis media (AOM) is unclear.

There is little evidence on ibuprofen’s impact on birth weight and premature delivery.

As a pharmacist, I’m often asked, “What’s the best pill for sleep?!” Believe it or not, the “best” solution does not lie in a pill.

The National Association of Chain Drug Stores (NACDS) has sent a letter to the governors of all 50 states, urging pharmacy patient care as a top priority in any changes to healthcare policy in 2017 and beyond.

Pharmacists have once more been ranked among the most honest and ethical professionals in the United States, according to the results of the latest Gallup poll on the topic.

Syringe services programs (SSPs) aim to reduce the spread of HIV among people who inject drugs (PWID), as use of shared needles puts them at high risk of contracting or transmitting the infection.

Persistent vaccine-induced immunity through the typical cold weather, high risk period, and into the subsequent seasons is important in areas with year-round influenza activity.

Several recent studies, blogs and articles have raised a question in my mind about how secure independant pharmacy practice is.

An antiretroviral vaginal ring is being investigated to quell the spread of HIV.

Boehringer Ingelheim has announced that the FDA has granted orphan drug designation to nintedanib, a triple angiokinase inhibitor, for the treatment of mesothelioma.